Mytide Therapeutics
Boston
About Mytide Therapeutics
Mytide is committed to providing peptides to serve a diverse array of applications. They intend to work closely with partners to overcome challenges in synthesizing and purifying particular classes of peptides of interest, identify useful peptide modifications, and design and construct peptide libraries. They provide initial partners access to their cloud platform for immediate ordering, properties calculator, order tracking, and interactive data display.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2022)
- Website: mytide.io
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/mytide-therapeutics-60798 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.